ADME stands for Absorption, Distribution, Metabolism, and Excretion. These are the four processes your body uses to handle any drug or foreign substance from the moment you take it to the moment it leaves your system. Together, they form the foundation of pharmacokinetics, the science of how drugs move through the body. Every medication you’ve ever taken has been studied through this framework before reaching the pharmacy shelf.
Absorption: How a Drug Enters Your Bloodstream
Absorption is the first step. When you swallow a pill, the drug needs to cross from your digestive tract into your blood. While the stomach plays a role, most absorption happens in the small intestine, where the surface area is vastly larger and the membranes are more permeable. Even acidic drugs that could technically cross stomach membranes are absorbed faster once they reach the intestine.
Drugs cross cell membranes in a few different ways. The most common is passive diffusion, where molecules simply move from an area of high concentration (your gut) to low concentration (your blood). How quickly this happens depends on the drug’s size, its ability to dissolve in fats, and how much of the intestinal surface it can contact. Some drugs that resemble natural substances your body already transports, like vitamins, sugars, or amino acids, get carried across by dedicated transport systems in what’s called active transport. A third mechanism, used mainly by large protein-based drugs, involves the cell membrane essentially swallowing the drug molecule whole.
Not every milligram you swallow makes it into circulation. After crossing the intestinal wall, a drug passes through the liver before reaching the rest of the body. The liver can break down a significant portion of the drug on this first pass, a phenomenon called the first-pass effect. The fraction that survives and enters general circulation is known as the drug’s bioavailability. This is one reason the same medication may come in different doses depending on whether it’s taken orally or given by injection, which bypasses the gut and liver entirely.
Distribution: Where the Drug Goes Next
Once a drug reaches the bloodstream, it doesn’t spread evenly to every tissue. Distribution describes how and where a drug travels after absorption. One of the biggest factors is protein binding. Drug molecules in the blood can latch onto plasma proteins, most commonly albumin. While bound to these proteins, a drug is essentially inactive. It can’t cross into tissues, can’t reach its target, and can’t produce any effect. Only the free, unbound portion of the drug does the actual work.
How much of a drug gets bound depends on its chemical properties. Acidic drugs tend to bind more heavily to albumin, while basic drugs bind to other plasma proteins like globulins. Molecular size matters too: very large molecules (over 500 daltons) can be more than 98% protein-bound, leaving only a tiny fraction free to act. This is why two drugs with identical doses can behave very differently in the body. It also explains why drug interactions can be dangerous. If a second drug competes for the same protein binding sites, it can displace the first drug, suddenly flooding the bloodstream with a higher-than-expected free concentration.
Distribution also depends on blood flow to specific organs and whether a drug can cross specialized barriers. The brain, for instance, is protected by a tightly sealed network of blood vessels that blocks most molecules. Only free (unbound) drug with the right chemical properties can cross this barrier and affect the central nervous system.
Metabolism: Breaking the Drug Down
Your body treats most drugs as foreign substances and works to chemically transform them into forms that are easier to eliminate. This process, metabolism, happens primarily in the liver and occurs in two phases.
Phase I reactions modify the drug molecule directly, typically by adding or exposing a chemical group that makes it more water-soluble. The heavy lifting here is done by a family of liver enzymes collectively known as cytochrome P450 (often abbreviated CYP450). These enzymes are responsible for metabolizing a huge proportion of all medications. The activity of CYP450 enzymes varies widely between individuals, which is one reason the same drug can work well in one person and cause side effects in another. Genetics, age, diet, and other medications all influence how active these enzymes are.
Phase II reactions take the modified molecule from Phase I and attach it to a larger, water-soluble compound. This conjugation step makes the drug even easier for the kidneys or bile to flush out. Phase II enzymes tend to be more consistent from person to person than Phase I enzymes, meaning less unpredictable variation. The two phases can work in sequence or independently, but the end goal is the same: converting the drug into something your body can readily excrete.
Metabolism doesn’t always deactivate a drug. Some medications are designed as “prodrugs,” meaning they’re inactive when you take them and only become effective after liver enzymes transform them into their active form.
Excretion: Clearing the Drug From Your Body
Excretion is the final step, the process of physically removing the drug and its metabolites from your body. The kidneys handle the majority of this work. Water-soluble compounds are filtered from the blood, passed into urine, and eliminated. The rate at which the kidneys clear a drug directly determines how long its effects last and how often you need to take another dose.
The liver contributes a second route through the biliary system. Some drugs, particularly larger molecules with both water-soluble and fat-soluble characteristics, are secreted into bile and passed into the intestine. From there, things get interesting. In a process called enterohepatic cycling, the drug can be reabsorbed from the intestine back into the bloodstream, effectively recycling itself. This only truly counts as excretion when the cycle is incomplete, meaning some of the drug passes through the gut without being reabsorbed and leaves the body in stool.
Minor excretion routes include sweat, saliva, breast milk, and exhaled air, though these account for a small fraction of total drug elimination for most medications.
Why ADME Matters in Drug Development
ADME isn’t just a textbook concept. It’s a core part of how new drugs are evaluated before they ever reach patients. Roughly 40% of experimental drug candidates fail during development because of poor ADME profiles. A drug that isn’t absorbed well enough, gets broken down too quickly, or can’t be cleared safely is unlikely to succeed no matter how well it works in a lab dish.
Regulatory agencies like the FDA require detailed ADME studies as part of the drug approval process. These include radiolabeled mass balance studies, where a small amount of radioactively tagged drug is given to volunteers so researchers can track exactly where the drug goes, how it’s metabolized, and how it’s eliminated. Computer modeling now plays a growing role in predicting ADME properties early in development, allowing researchers to screen out problematic compounds before they reach expensive human trials.
You’ll sometimes see the acronym extended to ADMET, with the “T” standing for Toxicity. This expanded framework accounts for the fact that a drug’s safety profile is inseparable from how the body handles it. About 30% of drugs that make it through development and reach the market are eventually withdrawn because of toxic reactions that weren’t fully predicted. Understanding ADME, and particularly how metabolism can produce harmful byproducts, is central to avoiding those outcomes.